Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02237612 · ClinicalTrials.gov registry record · NA

Diffusion-Weighted MRI in Staging Patients With Localized Prostate Cancer

A NA study of Adenocarcinoma of the Prostate and Stage IIB Prostate Cancer, sponsored by University of Southern California.

Completed
Registry status
NA
Development phase
9
Enrollment target
1
Study location

NCT02237612: Completed NA study of Adenocarcinoma of the Prostate and Stage IIB Prostate Cancer, sponsored by University of Southern California.

NCT02237612 is a NA study of Adenocarcinoma of the Prostate and Stage IIB Prostate Cancer that has completed, run by University of Southern California. The registered enrollment target is 9 participants, below the 109-participant average among 21 other Adenocarcinoma of the Prostate trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02237612, a NA study of Adenocarcinoma of the Prostate and Stage IIB Prostate Cancer, has completed, sponsored by University of Southern California.

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target
1
Study location

Study Summary

This pilot clinical trial studies how well diffusion-weighted magnetic resonance imaging (MRI) works in staging patients with prostate cancer that has not spread to nearby lymph nodes or other parts of the body. New imaging techniques, such as diffusion-weighted MRI, may be a less invasive way of predicting the stage and grade of prostate cancer.

Primary Outcome

Patients will be imaged using diffusion-weighted MR. Findings will be correlated with histopathologic findings at biopsy and/or prostatectomy.

Conditions Studied

Adenocarcinoma of the Prostate Stage IIB Prostate Cancer Stage IIA Prostate Cancer

Interventions

  • OTHER laboratory biomarker analysis
  • PROCEDURE diffusion-weighted magnetic resonance imaging

Study Locations (1)

California

  • USC Norris Comprehensive Cancer Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2009-01
Est. Completion 2013-03
Phase NA
University of Southern California

617 total trials

What the finished NCT02237612 record still lists

NCT02237612 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 109-participant average among 21 other Adenocarcinoma of the Prostate trials with a reported enrollment target (92% lower).

The record links to 3 conditions, with Adenocarcinoma of the Prostate appearing as the primary indexed condition, and to 2 interventions - of which laboratory biomarker analysis is the first listed.

NCT02237612 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT02237612 about?

NCT02237612 is a clinical study titled "Diffusion-Weighted MRI in Staging Patients With Localized Prostate Cancer". This pilot clinical trial studies how well diffusion-weighted magnetic resonance imaging (MRI) works in staging patients with prostate cancer that has not spread to nearby lymph nodes or other parts of the body. New imaging techniques, such as diffusion-weighted MRI, may be a less invasive way of pr...

What is the current status of trial NCT02237612?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2009-01. Estimated completion is 2013-03.

What conditions does trial NCT02237612 study?

This clinical trial studies the following conditions: Adenocarcinoma of the Prostate, Stage IIB Prostate Cancer, Stage IIA Prostate Cancer.

What interventions are being tested in trial NCT02237612?

The interventions under investigation include: laboratory biomarker analysis (OTHER), diffusion-weighted magnetic resonance imaging (PROCEDURE).

Who is sponsoring clinical trial NCT02237612?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02237612 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Adenocarcinoma of the Prostate

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02237612's enrollment target sits among peer trials

9 21st of 21 higher than 1 of 21 other Adenocarcinoma of the Prostate trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Adenocarcinoma of the Prostate trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT02237612, the US trial registry maintained by the National Library of Medicine. NCT02237612 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.